A increasing attention has emerged around GLP-1 Receptor medications, particularly Wegovy, for their effectiveness to treat type 2 diabetes and promote weight reduction. These innovative therapies, initially developed for diabetes care, have demonstrated remarkable benefits in helping individuals achieve their health objectives. While copyright are